Bovine Respiratory Disease Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031
상품코드:1879492
리서치사:Lucintel
발행일:2025년 11월
페이지 정보:영문 150 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계 소 호흡기질환 치료 시장은 동물병원, 수의 클리닉, 수의학 연구기관, 민간 동물약국 시장에서의 기회로 인해 미래가 밝을 것으로 예상됩니다. 세계 소 호흡기질환 치료제 시장은 2025년부터 2031년까지 CAGR 18.1%로 성장할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 가축 호흡기질환의 증가 추세, 가축 질병 관리에 대한 인식 증가, 고급 수의학에 대한 수요 증가입니다.
Lucintel의 예측에 따르면, 치료법 유형별로는 백신이 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다.
용도별로는 동물병원용이 가장 높은 성장률을 보일 것으로 예상됩니다.
지역별로는 아시아태평양(APAC)이 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다.
소 호흡기질환 치료 시장의 새로운 동향
가축 호흡기질환 치료 시장은 예방적, 데이터 기반, 지속가능한 건강 관리를 위한 새로운 트렌드로 인해 근본적인 변화의 시기를 맞이하고 있습니다. 이러한 추세는 바이오 보안 강화의 필요성, 항균제 내성에 대한 우려 증가에 대한 대응, 보다 효율적이고 윤리적인 농업 관행의 추진에 의해 주도되고 있습니다. 이는 생산자가 가축의 건강을 유지하는 방식을 근본적으로 바꾸고 있습니다.
정밀 축산 : 정밀 축산은 웨어러블 센서와 원격 모니터링 기술을 활용해 소의 건강 상태를 개체별로 추적하는 주요 트렌드입니다. 이를 통해 체온과 활동량 변화 등 소 호흡기질환(BRD) 증상을 조기에 발견할 수 있습니다. 그 결과, 질병 확산의 대폭적인 억제, 보다 정확한 치료, 군 관리 효율의 향상을 실현할 수 있습니다.
항균제 사용 감소 : 항균제 사용 감소 추세는 항생제 내성에 대한 전 세계적인 우려에 대한 직접적인 대응입니다. 이로 인해 프로바이오틱스, 사료 첨가제, 강화 백신 등 대체 건강 제품 개발이 촉진되고 있습니다. 광범위 항생제 사용에서 벗어나 집단 면역을 강화하는 예방책에 초점을 맞추는 방향으로 시장이 이동하고 있습니다.
첨단 백신 개발 : 양돈 의료 시장에서는 서브유닛 백신과 유전자재조합 백신을 포함한 첨단 백신 개발이 급증하고 있습니다. 이는 아프리카돼지열병(ASF)이나 돼지생식기호흡기증후군(PRRS)과 같은 전염성이 높은 질병과의 싸움에서 매우 중요합니다. 이를 통해 질병 발생에 대한 방어선을 강화하여 사망률과 경제적 손실을 줄일 수 있습니다.
진단 및 모니터링의 고도화 : 시장에서는 즉각적인 결과를 제공하는 신속한 농장 내 진단 검사에 대한 추세를 볼 수 있습니다. 이를 통해 BRD(소 호흡기질환)를 신속하고 정확하게 진단할 수 있으며, 수의사는 가장 효과적이고 타겟팅된 치료법을 처방할 수 있습니다. 이를 통해 광범위 항생제 사용을 줄이고 치료 성공률을 높일 수 있습니다.
통합 건강관리 시스템 : 진단, 치료 기록, 군집 데이터를 단일 플랫폼에 통합하는 시스템이 주요 트렌드로 부상하고 있습니다. 이를 통해 그룹 전체의 건강 상태를 종합적으로 파악할 수 있어 BRD 관리의 연계 강화가 가능합니다. 수의사와 생산자가 데이터에 기반한 의사결정을 내리고, 보다 효과적인 예방 전략을 실행할 수 있도록 돕습니다.
이러한 새로운 트렌드는 BRD 치료 시장을 기술적으로 통합적이고 예방적이며 지속가능한 방향으로 근본적으로 변화시키고 있습니다. 정밀농업으로의 전환, 항생제 사용량 감소, 첨단 진단 기술의 도입은 동물의 건강 상태를 개선할 뿐만 아니라 소비자와 규제 당국의 요구에 부응하는 보다 견고하고 현대적인 축산업을 실현할 수 있게 해줍니다.
소 호흡기질환 치료 시장의 최근 동향
최근 소 호흡기질환 치료 시장의 동향은 바이오 보안 강화, 진단 기술 향상, 혁신적인 예방 솔루션 개발에 초점을 맞추고 있습니다. 이러한 발전은 질병 발생의 지속적인 위협에 대응하고 안정적이고 안전한 육류 및 유제품 공급에 대한 전 세계적인 수요를 충족시키는 데 매우 중요합니다. 이러한 주요 발전은 기존 업무 흐름을 개선할 뿐만 아니라 동물 위생 분야의 새로운 가능성을 열어주고 있습니다.
새로운 항생제 개발 : 중요한 진전으로 BRD 치료에 특화된 새로운 장시간 작용하는 항생제가 도입되었습니다. 이 제품들은 효과의 향상과 단회 투여를 실현하고 소의 스트레스를 줄입니다. 이를 통해 동물 복지를 개선하고, 병든 소를 반복적으로 처리할 필요성을 줄이고, 보다 효과적인 치료 프로토콜을 구현할 수 있습니다.
비강 백신 채택 : BRD 예방을 위한 비강 백신의 채택이 시장에서 증가하고 있습니다. 이 백신은 기존 주사 백신에 비해 더 빠른 면역 발현을 제공합니다. 이러한 발전은 비육장에 도착한 고위험군 송아지에게 특히 효과적이며, 병원균에 대한 신속한 방어 반응을 가져와 이환율과 폐사율을 감소시킵니다.
웨어러블 건강 센서의 부상 : 소를 위한 웨어러블 건강 센서의 보급은 주요한 발전으로, 지속적인 실시간 건강 모니터링을 가능하게 합니다. 이 센서는 BRD의 초기 징후를 나타낼 수 있는 동물의 행동이나 체온의 미묘한 변화를 감지할 수 있습니다. 이를 통해 반응적 치료에서 예방적 치료로 전환하여 질병이 확산되기 전에 조기에 개입할 수 있습니다.
진단 도구의 고도화 : 신속한 농장 내 진단 검사의 보급은 큰 진전입니다. 수의사와 생산자는 이 간편한 검사를 통해 BRD를 유발하는 특정 병원균을 신속하게 식별할 수 있습니다. 이를 통해 표적 치료가 가능해져 광범위 항생제에 대한 의존도를 낮출 수 있습니다. 항균제 내성 대응을 위한 전 세계적인 노력을 지원합니다.
대체 요법에 대한 집중 : 프로바이오틱스, 사료 첨가제 등 장내 환경과 호흡기 건강을 개선하는 대체 요법에 대한 시장의 관심이 높아진 것이 주요한 발전입니다. 이는 무항생제 생산에 대한 추진이 그 배경에 있습니다. 이를 통해 BRD 관리는 보다 포괄적이고 예방적인 접근 방식으로 진화하여 동물의 자연 치유력을 강화하고 약리학적 개입의 필요성을 줄입니다.
새로운 항생제의 혁신적인 효과부터 웨어러블 센서의 보급에 이르기까지, 이러한 주요 발전이 결합하여 BRD 치료 시장의 진화를 촉진하고 있습니다. 이들은 치료의 정확성, 예방성, 지속가능성을 높이고, 새로운 응용 분야와 지역으로 시장을 확장하고 있습니다. 이러한 진화를 통해 BRD 의료는 사후 대응형에서 사전 예방형으로 변모하고 있습니다.
목차
제1장 주요 요약
제2장 시장 개요
배경과 분류
공급망
제3장 시장 동향과 예측 분석
업계 성장 촉진요인과 과제
PESTLE 분석
특허 분석
규제 환경
제4장 세계의 소 호흡기질환 치료 시장 : 종류별
매력 분석 : 종류별
백신
항생제
면역조절제
기타
제5장 세계의 소 호흡기질환 치료 시장 : 용도별
매력 분석 : 용도별
수의 클리닉
동물병원
수의학 연구기관
민간 수의 약국
제6장 지역 분석
제7장 북미의 소 호흡기질환 치료 시장
북미의 소 호흡기질환 치료 시장 : 종류별
북미의 소 호흡기질환 치료 시장 : 용도별
미국의 소 호흡기질환 치료 시장
멕시코의 소 호흡기질환 치료 시장
캐나다의 소 호흡기질환 치료 시장
제8장 유럽의 소 호흡기질환 치료 시장
유럽의 소 호흡기질환 치료 시장 : 종류별
유럽의 소 호흡기질환 치료 시장 : 용도별
독일의 소 호흡기질환 치료 시장
프랑스의 소 호흡기질환 치료 시장
스페인의 소 호흡기질환 치료 시장
이탈리아의 소 호흡기질환 치료 시장
영국의 소 호흡기질환 치료 시장
제9장 아시아태평양의 소 호흡기질환 치료 시장
아시아태평양의 소 호흡기질환 치료 시장 : 종류별
아시아태평양의 소 호흡기질환 치료 시장 : 용도별
일본의 소 호흡기질환 치료 시장
인도의 소 호흡기질환 치료 시장
중국의 소 호흡기질환 치료 시장
한국의 소 호흡기질환 치료 시장
인도네시아의 소 호흡기질환 치료 시장
제10장 기타 지역(ROW)의 소 호흡기질환 치료 시장
ROW의 소 호흡기질환 치료 시장 : 종류별
ROW의 소 호흡기질환 치료 시장 : 용도별
중동의 소 호흡기질환 치료 시장
남미의 소 호흡기질환 치료 시장
아프리카의 소 호흡기질환 치료 시장
제11장 경쟁 분석
제품 포트폴리오 분석
운영 통합
Porter's Five Forces 분석
시장 점유율 분석
제12장 기회와 전략 분석
밸류체인 분석
성장 기회 분석
세계의 소 호흡기질환 치료 시장 최신 동향
전략 분석
제13장 밸류체인 전반에 걸친 주요 기업 개요
경쟁 분석
Bayer HealthCare
Boehringer Ingelheim
Elanco
Merck
Zoetis
Ceva
Inovio Pharmaceuticals
제14장 부록
KSM
영문 목차
영문목차
The future of the global bovine respiratory disease treatment market looks promising with opportunities in the veterinary clinic, veterinary hospital, veterinary research institute, and private veterinary pharmacy markets. The global bovine respiratory disease treatment market is expected to grow with a CAGR of 18.1% from 2025 to 2031. The major drivers for this market are the increasing prevalence of bovine respiratory diseases, the rising awareness of livestock disease management, and the growing demand for advanced veterinary treatments.
Lucintel forecasts that, within the type category, vaccine is expected to witness the highest growth over the forecast period.
Within the application category, veterinary hospital is expected to witness the highest growth.
In terms of region, APAC is expected to witness the highest growth over the forecast period.
Emerging Trends in the Bovine Respiratory Disease Treatment Market
The bovine respiratory disease treatment market is undergoing a fundamental shift, with emerging trends that are making health management more proactive, data-driven, and sustainable. These trends are driven by the need for improved biosecurity, a response to growing concerns about antimicrobial resistance, and a push for more efficient and ethical farming practices. They are fundamentally changing how producers maintain herd health.
Precision Livestock Farming: Precision livestock farming is a key trend that uses technology like wearable sensors and remote monitoring to track individual cattle health. This allows for early detection of BRD symptoms, such as changes in temperature or activity. The impact is a significant reduction in disease spread, more targeted treatment, and improved herd management efficiency.
Reduced Antimicrobial Use: The trend toward reducing antimicrobial use is a direct response to global concerns about antibiotic resistance. This is driving the development of alternative health products, such as probiotics, feed additives, and enhanced vaccines. The impact is a market shift away from broad-spectrum antibiotic use and a focus on preventative measures to strengthen herd immunity.
Advanced Vaccine Development: The swine healthcare market is seeing a surge in the development of advanced vaccines, including subunit vaccines and genetically engineered vaccines. This is crucial for combating highly contagious diseases like African Swine Fever (ASF) and Porcine Reproductive and Respiratory Syndrome (PRRS). The impact is a more effective line of defense against disease outbreaks, reducing mortality and economic losses.
Enhanced Diagnostics and Monitoring: The market is seeing a trend toward rapid, on-farm diagnostic tests that provide immediate results. This allows for quick and accurate diagnosis of BRD, enabling veterinarians to prescribe the most effective, targeted treatment. The impact is a reduction in the use of broad-spectrum antibiotics and improved treatment success rates.
Integrated Health Management Systems: The rise of integrated health management systems is a key trend, combining diagnostics, treatment records, and herd data into a single platform. These systems provide a holistic view of herd health. The impact is a more coordinated approach to managing BRD, allowing veterinarians and producers to make data-driven decisions and implement more effective preventative strategies.
These emerging trends are fundamentally reshaping the BRD treatment market by making it more technologically integrated, proactive, and sustainable. The move toward precision farming, reduced antibiotic use, and advanced diagnostics is not only improving animal health but also ensuring a more resilient and modern cattle industry that meets the demands of consumers and regulators.
Recent Developments in the Bovine Respiratory Disease Treatment Market
Recent developments in the bovine respiratory disease treatment market are focused on enhancing biosecurity, improving diagnostics, and developing innovative preventative solutions. These advancements are critical for addressing the ongoing threat of disease outbreaks and for meeting the global demand for a stable and safe meat and dairy supply. These key developments are not only improving existing workflows but are also enabling new frontiers in animal health.
Development of Novel Antibiotics: A significant development is the introduction of new, long-acting antibiotics specifically designed for BRD treatment. These products offer improved efficacy and a single-dose administration, which reduces the stress on cattle. The impact is a more effective treatment protocol that improves animal welfare and reduces the need for repeated handling of sick animals.
Adoption of Intranasal Vaccines: The market has seen a growing adoption of intranasal vaccines for BRD prevention. These vaccines provide a faster onset of immunity compared to traditional injectable vaccines. This development is particularly impactful for high-risk calves upon arrival at feedlots, as it provides a quicker protective response against pathogens, reducing morbidity and mortality rates.
Rise of Wearable Health Sensors: The rise of wearable health sensors for cattle is a key development, allowing for continuous, real-time health monitoring. These sensors can detect subtle changes in an animal's behavior or temperature that may indicate early signs of BRD. The impact is a shift from reactive to proactive treatment, enabling early intervention before a disease becomes widespread.
Enhanced Diagnostic Tools: There is a significant development in the availability of rapid, on-farm diagnostic tests. These user-friendly tests allow veterinarians and producers to quickly identify the specific pathogens causing BRD. This enables the use of targeted treatments and helps reduce the reliance on broad-spectrum antibiotics, supporting global efforts to combat antimicrobial resistance.
Focus on Alternative Therapies: A key development is the market's growing focus on alternative therapies, such as probiotics and feed additives, that improve gut and respiratory health. This is driven by the push for antibiotic-free production. The impact is a more holistic, preventative approach to BRD management that strengthens the animal's natural defenses and reduces the need for pharmacological intervention.
These key developments, from the revolutionary power of new antibiotics to the accessibility of wearable sensors, are collectively driving the evolution of the BRD treatment market. They are enhancing precision, prevention, and sustainability, thereby expanding the market's reach into new applications and geographies. This evolution is reshaping BRD healthcare from a reactive to a proactive and preventative model.
Strategic Growth Opportunities in the Bovine Respiratory Disease Treatment Market
The bovine respiratory disease treatment market is rich with strategic growth opportunities across various key applications. These opportunities are driven by the increasing demand for high-quality, safe meat and dairy products, and the need for more efficient and sustainable farming practices. Leveraging these opportunities is essential for market players to gain a competitive edge and drive future innovation.
Vaccines and Biologics: The vaccines and biologics segment offers a major growth opportunity. The development of new, more effective vaccines, as well as advancements in vaccine administration methods, is critical for disease prevention. This is fueled by the need to protect large-scale commercial herds from significant economic losses and a global shift toward preventative healthcare to reduce antibiotic use.
Antibiotic-Free Alternatives: The feed additives and nutrition sector presents a significant growth opportunity. With the global push to reduce antibiotic use, there is a high demand for products like probiotics, prebiotics, and essential oils that can improve gut and respiratory health. This is driven by consumer and regulatory pressure for antibiotic-free beef and dairy.
Advanced Diagnostics: The diagnostics market presents a strategic opportunity, particularly for rapid, on-site testing. Early and accurate detection of diseases is crucial for preventing widespread outbreaks. The development of user-friendly diagnostic kits and automated monitoring systems is vital for modern farming. This is fueled by the need for enhanced biosecurity and proactive herd management.
Precision Livestock Farming: Precision livestock farming offers a high-value growth opportunity. Using data analytics and remote monitoring, producers can identify and treat sick animals earlier. This allows for a more personalized and efficient approach to healthcare. This opportunity is driven by the potential for increased productivity, reduced healthcare costs, and improved animal welfare.
Veterinary Telemedicine: Veterinary telemedicine and remote consultation services represent a key growth area. By using digital platforms, veterinarians can provide remote support and health management advice to farmers. This is fueled by the need for better access to professional expertise, particularly in remote areas, and improved communication between farmers and veterinarians for more effective BRD management.
These strategic growth opportunities across key applications are collectively driving the evolution of the BRD treatment market. The increasing need for sophisticated and preventative care for cattle is pushing the boundaries of what is possible, leading to a more dynamic and innovative market. Capitalizing on these opportunities is essential for sustained growth and technological leadership.
Bovine Respiratory Disease Treatment Market Driver and Challenges
The bovine respiratory disease treatment market is influenced by a complex interplay of drivers and challenges, including various technological, economic, and regulatory factors. The market is propelled by a rising demand for high-quality protein and a need for improved biosecurity, but it also faces significant barriers related to cost and a growing concern over antibiotic resistance. Understanding these dynamics is crucial for navigating the market.
The factors responsible for driving the bovine respiratory disease treatment market include:
1. Rising Global Demand for Protein: The increasing global demand for beef and dairy products is a primary market driver. This puts pressure on producers to ensure the health and productivity of their herds. BRD is a major cause of economic losses, prompting producers to invest in advanced treatments and preventative measures to maintain a stable and profitable supply.
2. Prevalence of BRD in Cattle: The high incidence and economic impact of BRD, particularly in feedlot calves, is a significant driver. The disease leads to major losses from reduced weight gain, treatment costs, and mortality. This consistent threat encourages producers to adopt proactive health management programs, creating a strong and stable market for BRD treatments and diagnostics.
3. Advancements in Veterinary Technology: Technological progress in vaccines, diagnostics, and therapeutic formulations is a key driver. The development of more effective, long-acting antibiotics and rapid on-farm tests makes BRD management more efficient. These innovations are improving treatment success rates and making advanced veterinary care more accessible to producers.
4. Government Regulations on Animal Health: Stricter government regulations and policies on animal health and food safety are a major driver. Governments are pushing for the responsible use of antibiotics and improved animal welfare standards. This regulatory pressure encourages producers to invest in alternative treatments and preventative healthcare, such as vaccines, to comply with new standards.
5. Shift to Intensive Farming: The global trend toward large-scale, intensive cattle farming is a significant driver. These operations are more susceptible to the rapid spread of diseases due to high animal density. This shift creates a large and stable market for high-value products like vaccines, therapeutics, and health management software to protect these valuable assets.
Challenges in the bovine respiratory disease treatment market are:
1. Antimicrobial Resistance Concerns: Public and regulatory concerns about antimicrobial resistance (AMR) pose a significant challenge. This pressure is pushing the industry to reduce the use of antibiotics, which can be difficult to manage, particularly during disease outbreaks. It requires a fundamental shift in farming practices and the development of alternative health products.
2. High Cost of Advanced Solutions: The high cost of advanced vaccines, diagnostic tools, and biosecurity equipment can be a significant barrier for smaller-scale farmers. This financial constraint limits the adoption of cutting-edge technologies and makes it difficult for these farmers to compete with large-scale operations that can afford to invest in comprehensive health management.
3. Diagnostic Challenges: The complex, multifactorial nature of BRD makes accurate and early diagnosis challenging. Clinical signs can be non-specific, leading to delayed treatment or misdiagnosis. This challenge can result in a reliance on broad-spectrum antibiotics and limits the effectiveness of targeted treatments, hindering the overall progress in combating the disease.
The bovine respiratory disease treatment market is driven by powerful forces, including growing global demand for protein and technological advancements. However, it is also constrained by significant challenges, particularly the ongoing threat of disease outbreaks and the pressure to reduce antibiotic use. For the market to continue its robust growth, it must effectively address these challenges by providing innovative and cost-effective solutions that are accessible to all types of producers.
List of Bovine Respiratory Disease Treatment Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bovine respiratory disease treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bovine respiratory disease treatment companies profiled in this report include-
Bayer HealthCare
Boehringer Ingelheim
Elanco
Merck
Zoetis
Ceva
Inovio Pharmaceuticals
Bovine Respiratory Disease Treatment Market by Segment
The study includes a forecast for the global bovine respiratory disease treatment market by type, application, and region.
Bovine Respiratory Disease Treatment Market by Type [Value from 2019 to 2031]:
Vaccines
Antibiotics
Immunomodulators
Others
Bovine Respiratory Disease Treatment Market by Application [Value from 2019 to 2031]:
Veterinary Clinics
Veterinary Hospitals
Veterinary Research Institutes
Private Veterinary Pharmacies
Country Wise Outlook for the Bovine Respiratory Disease Treatment Market
Recent developments in the bovine respiratory disease treatment market are driven by a global push for more effective disease management and a reduction in antibiotic use. The focus is shifting from a purely reactive, antibiotic-centric approach to one that emphasizes prevention, early detection, and integrated health solutions. This is critical for improving animal welfare and securing the economic viability of the cattle industry.
United States: The U.S. market is a leader in advanced therapeutics and diagnostics, driven by large-scale feedlot operations and significant economic losses from BRD. Recent developments include the launch of new, single-dose, long-acting antibiotics and a growing adoption of precision livestock farming technologies like wearable sensors for early disease detection.
China: China's BRD treatment market is rapidly modernizing, propelled by a shift from small-scale to large-scale, commercial cattle farming. Recent developments are focused on building modern veterinary infrastructure and adopting Western-style health protocols. There is a high demand for advanced vaccines and therapeutics to improve herd health and meet rising consumer demand for beef and dairy.
Germany: The German market is characterized by a strong emphasis on responsible antibiotic use and animal welfare. Recent developments are centered on preventive health strategies, including advanced vaccination programs and alternative treatments like immunomodulators. The market is also seeing a rise in the use of sophisticated diagnostics to ensure targeted, rather than broad-spectrum, treatment.
India: India's BRD treatment market is in a growth phase, driven by a large cattle population and increasing commercialization of dairy farming. Recent developments include a growing awareness of modern veterinary practices and the entry of global animal health companies. There is a rising demand for affordable vaccines and treatments to reduce morbidity and mortality in cattle.
Japan: Japan's BRD market is highly developed, with a proactive approach to disease prevention and food safety. Recent developments are driven by a cultural focus on quality. The market is investing in innovative solutions, including genomic research to identify disease-resistant breeds and the use of advanced diagnostics to ensure herd health and maintain the high standards of its beef and dairy products.
Features of the Global Bovine Respiratory Disease Treatment Market
Market Size Estimates: Bovine respiratory disease treatment market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Bovine respiratory disease treatment market size by type, application, and region in terms of value ($B).
Regional Analysis: Bovine respiratory disease treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the bovine respiratory disease treatment market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bovine respiratory disease treatment market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the bovine respiratory disease treatment market by type (vaccines, antibiotics, immunomodulators, and others), application (veterinary clinics, veterinary hospitals, veterinary research institutes, and private veterinary pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Table of Contents
1. Executive Summary
2. Market Overview
2.1 Background and Classifications
2.2 Supply Chain
3. Market Trends & Forecast Analysis
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment
4. Global Bovine Respiratory Disease Treatment Market by Type
4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 Vaccines: Trends and Forecast (2019-2031)
4.4 Antibiotics: Trends and Forecast (2019-2031)
4.5 Immunomodulators: Trends and Forecast (2019-2031)
4.6 Others: Trends and Forecast (2019-2031)
5. Global Bovine Respiratory Disease Treatment Market by Application
5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 Veterinary Clinics: Trends and Forecast (2019-2031)
5.4 Veterinary Hospitals: Trends and Forecast (2019-2031)
5.5 Veterinary Research Institutes: Trends and Forecast (2019-2031)
5.6 Private Veterinary Pharmacies: Trends and Forecast (2019-2031)
6. Regional Analysis
6.1 Overview
6.2 Global Bovine Respiratory Disease Treatment Market by Region
7. North American Bovine Respiratory Disease Treatment Market
7.1 Overview
7.2 North American Bovine Respiratory Disease Treatment Market by Type
7.3 North American Bovine Respiratory Disease Treatment Market by Application
7.4 United States Bovine Respiratory Disease Treatment Market
